AdvanCell is a clinical stage radiopharmaceutical company developing treatments to significantly improve survival and quality of life, providing new hope for patients with currently uncurable cancers.

EMVision is an innovative medical device company which is developing a portable brain scanner set to revolutionise stroke care.

Infensa Bioscience is developing therapeutics to treat two of the leading causes of death worldwide – stroke and heart attack.

Microba uses DNA to analyse gut microbes to help develop diagnostics and targeted biotherapeutic remedies for diseases such as inflammatory bowel disease, colon cancer, diabetes and depression.

Microbio is developing InfectID, a revolutionary pathogen identification test – rapid, highly sensitive and adaptable to address different target pathogens. Microbio’s initial product is a bloodstream infection / sepsis pathogen identification blood test with no need to pre-culture.

Ocugene – develops next generation retinal therapeutics and gene delivery vectors with enhanced safety profiles for diseases such as macular degeneration, uveitis and uveal melanoma.

Oroborus is a chemistry technology company that is focused on stabilising and modifying natural peptides into more useful drug-like compounds.

The National Imaging Facility (NIF) – Their mission is to make cutting-edge imaging capabilities accessible to Australian medical researchers, and material and agriculture scientists enabling them to solve challenges across research and industry.

MTPConnect -is a not-for-profit organisation aiming to accelerate the rate of growth of the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia.

Vale Life Sciences – Vale’s patented products – Happy Cell® ASM (primarily used for the 3D cell culture market), and Bioclime+ 96 (microplate system that substantially lowers the costs of cell and tissue-based research) – are used worldwide by researchers.

Vaxxas is a privately held biotechnology company focussed on enhancing the performance of existing and next generation vaccines and increasing access to vaccination, through its proprietary needle-free vaccine technology, the high-density microarray patch (HD-MAP).

360biolabs – is Australia’s most comprehensive speciality laboratory services organisation for therapeutic, vaccine and diagnostics development. 360biolabs supports bioanalysis for new and established small molecules, peptides, proteins and biologics.

Brandon Capital is Australasia’s leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK.

Health Translation Queensland – As an NHMRC accredited Advanced Health Research and Translation Centre, Health Translation Queensland works to mobilise research into clinical practice, and support health systems and business transformation.

Life Sciences Queensland (LSQ) – Life Sciences Queensland Limited provides opportunities for industry stakeholders to collaborate and grow their businesses and help create a dynamic, internationally competitive and sustainable life sciences industry in Queensland, Australia.

Patheon ThermoFisher – dedicated to supporting the needs of biotechnology, pharmaceutical, and life sciences companies with their end-to-end CDMO capabilities and technical expertise.

Therapeutic Innovation Australia (TIA) – TIA supports national research infrastructure across three capabilities – Biologics & Vaccines, Cell & Gene Therapies, and Small Molecule Pharmaceuticals.